Differential roles of STAT3 in the initiation and growth of lung cancer

Jingjiao Zhou1,2, Zhaoxia Qu1,2, Shapei Yan1,2

  • 1University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.

Oncogene
|October 7, 2014
PubMed

Insights

Signal transducer and activator of transcription 3 (STAT3) plays a dual role in lung cancer. It prevents tumor initiation by maintaining homeostasis but promotes cancer growth once established, offering therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pulmonary Medicine

Background:

  • Signal transducer and activator of transcription 3 (STAT3) is implicated in various cancers, including lung adenocarcinoma.
  • The precise role of STAT3 in lung cancer development and progression remains unclear.

Purpose of the Study:

  • To elucidate the specific functions of STAT3 in lung cancer initiation and growth.
  • To investigate the contrasting roles of STAT3 in different stages of lung cancer pathogenesis.

Main Methods:

  • Utilized lung epithelial-specific inducible knockout mouse models.
  • Induced lung cancer using chemical carcinogens (urethane) and genetic manipulations (oncogenic K-Ras).
  • Assessed lung tissue damage, inflammation, oncogenic mutations, and tumor cell proliferation.

Main Results:

  • Deleting STAT3 before cancer induction increased lung damage, inflammation, K-Ras mutations, and tumorigenesis.
  • Deleting STAT3 after cancer establishment inhibited tumor cell proliferation.
  • Simultaneous deletion of STAT3 and K-Ras expression led to increased injury, inflammation, and tumorigenesis, but reduced tumor growth.

Conclusions:

  • STAT3 acts as a tumor suppressor in lung cancer initiation by preserving pulmonary homeostasis under stress.
  • STAT3 functions as an oncogene in lung cancer progression by promoting cancer cell proliferation.
  • These findings provide a mechanistic rationale for targeting STAT3 in lung cancer therapy.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K
Tumor Progression02:07

Tumor Progression

3.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K